Compare ETON & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | RWT |
|---|---|---|
| Founded | 2017 | 1994 |
| Country | United States | United States |
| Employees | N/A | 351 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.7M | 707.5M |
| IPO Year | 2018 | N/A |
| Metric | ETON | RWT |
|---|---|---|
| Price | $25.88 | $5.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $39.33 | $6.91 |
| AVG Volume (30 Days) | 468.4K | ★ 1.4M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 12.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $26.59 |
| Revenue Next Year | $47.23 | $22.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $5.00 |
| 52 Week High | $27.19 | $6.97 |
| Indicator | ETON | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 68.66 | 58.19 |
| Support Level | $16.79 | $5.91 |
| Resistance Level | N/A | $5.98 |
| Average True Range (ATR) | 1.31 | 0.14 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 73.61 | 95.00 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.